Competing against sutures and staples, advanced wound closure, sealing, hemostasis and anti-adhesion products are steadily gaining revenues. A new February 2012 report from MedMarket Diligence details this global $14 billion market.
Apr 13, 2012 – Foothill Ranch, California - Traditional use of sutures and, more recently, staples and clips largely represents the target for advanced wound closure and securement products including fibrin (and other) sealants, hemostats, high strength glues and post-surgical adhesion prevention products. Manufacturers of advanced wound closure and securement have over the past decade learned many lessons about clinical applications, surgical practices and market need and have developed broad portfolios of products that succeed in meeting that need.
The pace of development of products for wound sealing, closure, hemostasis and anti-adhesion has not slowed despite the extent to which these products have deeply penetrated the clinical caseload in the management of traumatic and surgical wounds. Traditional wound closure methods, including sutures, clips and tapes, have been steadily either displaced or augmented by biologically and chemically-derived formulations that produce more rapid healing, less scarring, less blood loss, less infection and fewer complications. MedMarket Diligence details the associated products, technologies, companies and global market in its 2012 report, "Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2010-2017."
"The successes of advanced wound closure products in effecting reduced blood loss, faster healing time and better clinical outcomes have justified their continued expansion into caseload traditionally addressed by sutures, a growth that has been only partially mitigated by absorbable sutures," says Patrick Driscoll, President of MedMarket Diligence. According to Driscoll, the continued growth of these novel products in the closure and management of wounds will result in sutures and staples declining from 35% of the total in 2012 to about 31% in 2017, with fibrin (and other) sealants and high strength medical adhesives being the primary beneficiaries. Moreover, these shifts in the market balance are taking place concurrent with an aggregate 8% annual increase in the market.
The breadth of wound closure products of course encompasses traditional wound closure based on mechanical closure, non-resorbable sutures, resorbable sutures, staples, clips and other types, as well as surgical tapes. While this category of products is undergoing a siege from biologically and chemically based closure products, the traditional wound closure types are seeing continued product development focused on improving outcomes and otherwise competing more effectively against emerging wound closure technologies. Due to their well established use in clinical practice, and due to the value of adjunctive use of these products with emerging products, this category remains the largest share of the wound closure and securement market.
Hemostats are now formulated from thrombin, gelatin, collagen, fibrin, synthetic and other types by literally dozens of companies.
Surgical sealants are derived from fibrin, synthetics, biopolymers, device-based and other types. These products represent the fastest-growing segment of the wound closure and securement market.
High strength medical and surgical glues and adhesives are, in principle, designed to achieve wound closure with little or no dependence on sutures, staples or other mechanical closure. Predicated on cyanoacrylate-type formulations, these products often have the advantage of stronger closure offset by toxicity, which has been the subject of aggressive development efforts. As a result of the successes that have been achieved in development and clinical acceptance, these products are demonstrating market growth that is second only to fibrin sealants.
Anti-adhesion (i.e., the prevention of post-surgical adhesions), seemingly the antithesis to surgical sealants and glues, can in fact be addressed by different formulations of products otherwise used for wound sealing, in addition by hyaluronic acids, biopolymers and other products specifically formulated to prevent tissue adhesion. Given the overlapping development of technologies and participating companies, this segment is a natural complement to consideration of wound closure products and technologies.
The MedMarket Diligence report #S190, detailed at http://www.mediligence.com/rpt/rpt-s190.htm details the complete range of wound securement technologies used in traumatic, surgical and other wound closure, from tapes, sutures and staples to hemostats, fibrin sealants/glues and medical adhesives. The report details current clinical and technology developments in this huge and rapidly growing worldwide market, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity.
The report is a market and technology assessment and forecast of surgical sealants, glues, hemostasis, other wound closure and anti-adhesion. The report details the current and emerging products, technologies and markets involved in wound closure and sealing using sutures and staples, tapes, hemostats, fibrin and sealant products, medical adhesives and products to prevent surgical adhesions. With full year actual data from 2011, the report provides a worldwide forecast to 2017 of the markets for these technologies, with particular emphasis on the market impact of new technologies through the coming decade. The report provides specific forecasts and shares of the worldwide market by segment for the U.S., Europe (United Kingdom, German, France, Italy, BeNeLux), Latin America, Japan, Korea and Rest of World.
The report provides background data on the surgical, disease and traumatic wound patient populations targeted by current technologies and those under development, and the current clinical practices in the management of these patients, including the dynamics among the various clinical specialties or subspecialties vying for patient population and facilitating or limiting the growth of technologies.
The report establishes the current worldwide market size for major technology segments as a baseline for and projecting growth in the market over a five-year forecast. The report also assesses and projects the composition of the market as technologies gain or lose relative market performance over this period.
The report may be purchased for immediate download via http://www.mediligence.com/store/page43.html or may be purchased by order form at https://www.mediligence.com/order_forms/s190_order.pdf.